Furthermore, this study confirmed that the anti-PSMA antibody functionalized PSMA-targeting GNPs are effective radiosensitizers for prostate cancer cells through a clonogenic assay and γ-H2AX assay. The gene discussed is H2AX; the disease is prostate carcinoma.